Related Experiment Videos

[Diagnostic value of C-reactive protein and D-dimer in deep venous thrombosis]

B Jøssang1, I Runde

  • 1Medisinsk avdeling, Aust-Agder Sentralsjukehus, Arendal.

Insights

C-reactive protein (CRP) demonstrates 100% sensitivity for excluding deep venous thrombosis, while D-dimer shows low sensitivity but high specificity. Combined screening could reduce venography needs by 38%.

Area of Science:

  • Medical diagnostics
  • Biomarker analysis
  • Vascular medicine

Background:

  • Deep venous thrombosis (DVT) diagnosis often relies on invasive procedures like phlebography.
  • Accurate and non-invasive biomarkers are crucial for efficient DVT screening.
  • C-reactive protein (CRP) and D-dimer are commonly assessed biomarkers in suspected thrombosis.

Purpose of the Study:

  • To compare the diagnostic accuracy of C-reactive protein (CRP) and D-dimer against phlebography for deep venous thrombosis (DVT).
  • To evaluate the potential of CRP and D-dimer as screening tools to reduce the need for venography.

Main Methods:

  • A consecutive series of 69 hospitalized patients with suspected leg thrombosis were included.
  • Phlebography served as the gold standard for DVT diagnosis.
  • Sensitivity and specificity of CRP and D-dimer were calculated and compared to phlebography findings.

Main Results:

  • C-reactive protein (CRP) exhibited 100% sensitivity, effectively excluding DVT.
  • D-dimer showed insufficient sensitivity to rule out DVT but achieved 100% specificity at a high discrimination limit, confirming DVT.
  • Integrated screening with CRP and D-dimer could potentially decrease venography requirements by 38%.

Conclusions:

  • CRP is a highly sensitive biomarker for ruling out DVT.
  • D-dimer, while less sensitive, is specific for confirming DVT when used with a high discrimination threshold.
  • Combined biomarker screening offers a promising strategy to optimize DVT diagnostic pathways and reduce reliance on venography.

Related Concept Videos